Showing metabocard for N-Acetyl-L-Glutamic acid_4-thiazolidine-carboxylic-acid (MMDBc0060921)
Microbial
| Record Information | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Version | 2.0 | ||||||||||||
| Status | Detected and Quantified | ||||||||||||
| Creation Date | 2025-10-03 01:02:54 UTC | ||||||||||||
| Update Date | 2025-10-08 21:35:31 UTC | ||||||||||||
| Metabolite ID | MMDBc0060921 | ||||||||||||
| Metabolite Identification | |||||||||||||
| Common Name | N-Acetyl-L-Glutamic acid_4-thiazolidine-carboxylic-acid | ||||||||||||
| Description | N-Acetyl-L-Glutamic acid_4-thiazolidine-carboxylic-acid is a thiazolidine derivative of an amino acid, specifically classified within the group of amino acid metabolites. There is limited literature available on this metabolite, indicating a need for further research to elucidate its biological significance and potential applications. | ||||||||||||
| Structure |  | ||||||||||||
| Synonyms | Not Available | ||||||||||||
| Molecular Formula | C11H16N2O6S | ||||||||||||
| Average Mass | 304.32 | ||||||||||||
| Monoisotopic Mass | 304.072907417 | ||||||||||||
| IUPAC Name | Not Available | ||||||||||||
| Traditional Name | Not Available | ||||||||||||
| CAS Registry Number | Not Available | ||||||||||||
| SMILES | Not Available | ||||||||||||
| InChI Identifier | Not Available | ||||||||||||
| InChI Key | QPIYASJRNKRUGN-MQWKRIRWSA-N | ||||||||||||
| Chemical Taxonomy | |||||||||||||
| Functional Ontology | |||||||||||||
| Not Available | |||||||||||||
| Physical Properties | |||||||||||||
| State | Not Available | ||||||||||||
| Predicted Properties | Not Available | ||||||||||||
| Spectra | |||||||||||||
| Not Available | |||||||||||||
| Biological Properties | |||||||||||||
| Cellular Locations | Not Available | ||||||||||||
| Biospecimen Locations | Not Available | ||||||||||||
| Tissue Locations | Not Available | ||||||||||||
| Associated OMIM IDs | |||||||||||||
| Human Proteins and Enzymes | |||||||||||||
| |||||||||||||
| Human Pathways | |||||||||||||
| Pathways |
| ||||||||||||
| Microbial Pathways | |||||||||||||
| Pathways | This table shows at most 5 pathways. For the full list of associated pathways: See All Associated Bacterial Pathways
| ||||||||||||
| Metabolic Reactions | |||||||||||||
Reactions This table shows at most 20 reactions. For the full list of associated reactions: See All Associated Reactions
| |||||||||||||
| Health Effects and Bioactivity | |||||||||||||
| |||||||||||||
| Microbial Sources | |||||||||||||
| |||||||||||||
| Exposure Sources | |||||||||||||
| Other Exposures |
| ||||||||||||
| Host Biospecimen and Location | |||||||||||||
| |||||||||||||
| External Links | |||||||||||||
| CMMC Knowledgebase | QPIYASJRNKRUGN-MQWKRIRWSA-N | ||||||||||||
| References | |||||||||||||
| Synthesis Reference | Not Available | ||||||||||||
| General References |
| ||||||||||||
